CANCER THERAPEUTICS CRC PTY LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07D HETEROCYCLIC COMPOUNDS 6156
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A63F CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; GAMES NOT OTHERWISE PROVIDED FOR 178

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0222,005 2-(HETERO)ARYL-BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF ASPARAGIME EMETHYL TRANSFERASEFeb 20, 14Aug 04, 16[C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9856252 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferaseFeb 20, 14Jan 02, 18[C07D]
9421205 FAK inhibitorsFeb 11, 15Aug 23, 16[A61K]
9390588 Systems and methods for determining and outputting outcomes for an event instance of a gameJul 06, 12Jul 12, 16[A63F, G07F]
9266864 VEGFR3 inhibitorsAug 16, 13Feb 23, 16[A61K, C07D]
9238644 VEGFR3 inhibitorsAug 16, 13Jan 19, 16[A61K, C07D]
9174946 Selective FAK inhibitorsFeb 17, 12Nov 03, 15[A61K, C07D]
9120761 Selective FAK inhibitorsJul 06, 12Sep 01, 15[A61K, C07D]
9012461 FAK inhibitorsJul 06, 12Apr 21, 15[A61K, A01N, C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0009,686 VEGFR3 INHIBITORSAbandonedAug 16, 13Jan 14, 16[C07D]
2015/0225,377 VEGFR3 INHIBITORSAbandonedAug 16, 13Aug 13, 15[A61K, C07D]
2013/0324,532 FAK INHIBITORSAbandonedFeb 17, 12Dec 05, 13[C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.